| [1] |
Glyn-Jones S, Palmer AJR, Agricola R, et al. Osteoarthritis[J]. Lancet, 2015, 386(9991): 376－387.
|
| [2] |
Hunter DJ, Bierma-Zeinstra S. Osteoarthritis[J]. Lancet, 2019, 393(10182): 1745－1759.
|
| [3] |
Motta F, Barone E, Sica A, et al. Inflammaging and osteoarthritis[J]. Clin Rev Allergy Immunol, 2023, 64(2): 222－238.
|
| [4] |
Li YS, Luo W, Zhu SA, et al. T cells in osteoarthritis: alterations and beyond[J/OL]. Front Immunol, 2017, 8: 356. DOI: 10.3389/fimmu.2017.00356.
|
| [5] |
Amaya-Uribe L, Rojas M, Azizi G, et al. Primary immunodeficiency and autoimmunity: a comprehensive review[J]. J Autoimmun, 2019, 99: 52－72.
|
| [6] |
Damasceno LEA, Prado DS, Veras FP, et al. PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation[J/OL]. J Exp Med, 2020, 217(10): e20190613. DOI: 10.1084/jem.20190613.
|
| [7] |
Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases[J]. Semin Immunopathol, 2019, 41(3): 283－297.
|
| [8] |
Storelli E, Cassina N, Rasini E, et al. Do Th17 lymphocytes and IL-17 contribute to Parkinson’s disease? A systematic review of available evidence[J/OL]. Front Neurol, 2019, 10: 13. DOI: 10.3389/fneur.2019.00013.
|
| [9] |
Agalioti T, Cortesi F, Gagliani N. T H17 cell immune adaptation[J/OL]. Curr Opin Immunol, 2023, 83: 102333. DOI: 10.1016/j.coi.2023.102333.
|
| [10] |
McGeachy MJ, Cua DJ, Gaffen SL. The IL-17 family of cytokines in health and disease[J]. Immunity, 2019, 50(4): 892－906.
|
| [11] |
Wu B, Wan Y. Molecular control of pathogenic Th17 cells in autoimmune diseases[J/OL]. Int Immunopharmacol, 2020, 80: 106187. DOI: 10.1016/j.intimp.2020.106187.
|
| [12] |
Rosshirt N, Trauth R, Platzer H, et al. Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis[J/OL]. Arthritis Res Ther, 2021, 23(1): 37. DOI: 10.1186/s13075-020-02410-w.
|
| [13] |
Walsh MC, Choi Y. Regulation of T cell-associated tissues and T cell activation by RANKL-RANK-OPG[J]. J Bone Miner Metab, 2021, 39(1): 54－63.
|
| [14] |
Zhu L, Hua F, Ding W, et al. The correlation between the Th17/Treg cell balance and bone health[J/OL]. Immun Ageing, 2020, 17: 30. DOI: 10.1186/s12979-020-00202-z.
|
| [15] |
Shui XL, Lin W, Mao CW, et al. Blockade of IL-17 alleviated inflammation in rat arthritis and MMP-13 expression[J]. Eur Rev Med Pharmacol Sci, 2017, 21(10): 2329－2337.
|
| [16] |
Park HL, Lee SM, Min JK, et al. IK acts as an immunoregulator of inflammatory arthritis by suppressing T H17 cell differentiation and macrophage activation[J/OL]. Sci Rep, 2017, 7: 40280. DOI: 10.1038/srep40280.
|
| [17] |
Mimpen JY, Baldwin MJ, Cribbs AP, et al. Interleukin-17A causes osteoarthritis-like transcriptional changes in human osteoarthritis-derived chondrocytes and synovial fibroblasts in vitro[J/OL]. Front Immunol, 2021, 12: 676173. DOI: 10.3389/fimmu.2021.676173.
|
| [18] |
Jiang L, Zhou X, Xiong Y, et al. Association between interleukin-17A/F single nucleotide polymorphisms and susceptibility to osteoarthritis in a Chinese population[J/OL]. Medicine, 2019, 98(12): e14944. DOI: 10.1097/MD.0000000000014944.
|
| [19] |
Liu SC, Hsieh HL, Tsai CH, et al. CCN2 facilitates IL-17 production and osteoclastogenesis in human osteoarthritis synovial fibroblasts by inhibiting miR-655 expression[J]. J Bone Miner Res, 2022, 37(10): 1944－1955.
|
| [20] |
Na HS, Park JS, Cho KH, et al. Interleukin-1-interleukin-17 signaling axis induces cartilage destruction and promotes experimental osteoarthritis[J/OL]. Front Immunol, 2020, 11: 730. DOI: 10.3389/fimmu.2020.00730.
|
| [21] |
李文金，薛庆云. 白细胞介素家族炎性细胞因子在骨关节炎中的研究进展[J/OL]. 中华关节外科杂志(电子版), 2023, 17(3): 348－353.
|
| [22] |
Shan Y, Qi C, Liu Y, et al. Increased frequency of peripheral blood follicular helper T cells and elevated serum IL-21 levels in patients with knee osteoarthritis[J]. Mol Med Rep, 2017, 15(3): 1095－1102.
|
| [23] |
Yi C, Yi Y, Wei J, et al. Targeting IL-22 and IL-22R protects against experimental osteoarthritis[J]. Cell Mol Immunol, 2021, 18(5): 1329－1331.
|
| [24] |
Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol, 1995, 155(3): 1151－1164.
|
| [25] |
Ohkura N, Sakaguchi S. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases[J]. Cell Res, 2020, 30(6): 465－474.
|
| [26] |
Fischer L, Herkner C, Kitte R, et al. Foxp3 ＋regulatory T cells in bone and hematopoietic homeostasis[J/OL]. Front Endocrinol, 2019, 10: 578. DOI: 10.3389/fendo.2019.00578.
|
| [27] |
Sakaguchi S, Mikami N, Wing JB, et al. Regulatory T cells and human disease[J]. Annu Rev Immunol, 2020, 38: 541－566.
|
| [28] |
Bozec A, Zaiss MM. T regulatory cells in bone remodelling[J]. Curr Osteoporos Rep, 2017, 15(3): 121－125.
|
| [29] |
Kang IH, Baliga UK, Chatterjee S, et al. Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta[J/OL]. iScience, 2022, 25(9): 104818. DOI: 10.1016/j.isci.2022.104818.
|
| [30] |
Ragni E, Colombini A, Viganò M, et al. Cartilage protective and immunomodulatory features of osteoarthritis synovial fluid-treated adipose-derived mesenchymal stem cells secreted factors and extracellular vesicles-embedded miRNAs[J/OL]. Cells, 2021, 10(5): 1072. DOI: 10.3390/cells10051072.
|
| [31] |
Penatti A, Facciotti F, de Matteis R, et al. Differences in serum and synovial CD4 ＋ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis[J/OL]. Arthritis Res Ther, 2017, 19(1): 103. DOI: 10.1186/s13075-017-1305-1.
|
| [32] |
|
| [33] |
Wojdasiewicz P, Poniatowski ŁA, Szukiewicz D. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis[J/OL]. Mediators Inflamm, 2014, 2014: 561459. DOI: 10.1155/2014/561459.
|
| [34] |
Li S, Wan J, Anderson W, et al. Downregulation of IL-10 secretion by Treg cells in osteoarthritis is associated with a reduction in Tim-3 expression[J]. Biomedecine Pharmacother, 2016, 79: 159－165.
|
| [35] |
Oh S, Rankin AL, Caton AJ. CD4＋CD25＋ regulatory T cells in autoimmune arthritis[J]. Immunol Rev, 2010, 233(1): 97－111.
|
| [36] |
Levescot A, Chang MH, Schnell J, et al. IL-1β-driven osteoclastogenic Tregs accelerate bone erosion in arthritis[J/OL]. JClinInvest, 2021, 131(18): e141008. DOI: 10.1172/JCI141008.
|
| [37] |
Wang J, Zhao X, Wan YY. Intricacies of TGF-β signaling in Treg and Th17 cell biology[J]. Cell Mol Immunol, 2023, 20(9): 1002－1022.
|
| [38] |
Park SH, Jung HJ, Kim TS. IL-33 changes CD25hi Tregs to Th17 cells through a dendritic cell-mediated pathway[J]. Immunol Lett, 2020, 218: 5－10.
|
| [39] |
Fan X, Chi G, Yan L, et al. Treg-promoted new bone formation through suppressing TH17 by secreting interleukin-10 in ankylosing spondylitis[J/OL]. Spine, 2019, 44(23): E1349-E1355. DOI: 10.1097/BRS.0000000000003169.
|
| [40] |
Knochelmann HM, Dwyer CJ, Bailey SR, et al. When worlds collide: Th17 and Treg cells in cancer and autoimmunity[J]. Cell Mol Immunol, 2018, 15(5): 458－469.
|
| [41] |
Rosshirt N, Hagmann S, Tripel E, et al. A predominant Th1 polarization is present in synovial fluid of end-stage osteoarthritic knee joints: analysis of peripheral blood, synovial fluid and synovial membrane[J]. Clin Exp Immunol, 2019, 195(3): 395－406.
|
| [42] |
Atabaki M, Shariati-Sarabi Z, Tavakkol-Afshari J, et al. Significant immunomodulatory properties of curcumin in patients with osteoarthritis; a successful clinical trial in Iran[J/OL]. Int Immunopharmacol, 2020, 85: 106607. DOI: 10.1016/j.intimp.2020.106607.
|
| [43] |
Nedunchezhiyan U, Varughese I, Sun AR, et al. Obesity, inflammation, and immune system in osteoarthritis[J/OL]. Front Immunol, 2022, 13: 907750. DOI: 10.3389/fimmu.2022.907750.
|
| [44] |
Jhun J, Min HK, Na HS, et al. Combinatmarion treatment with Lactobacillus acidophilus LA-1, vitamin B, and curcumin ameliorates the progression of osteoarthritis by inhibiting the pro-inflammatory mediators[J]. Immunol Lett, 2020, 228: 112－121.
|
| [45] |
Kwon JY, Lee SH, Na HS, et al. Kartogenin inhibits pain behavior, chondrocyte inflammation, and attenuates osteoarthritis progression in mice through induction of IL-10[J/OL]. Sci Rep, 2018, 8(1): 13832. DOI: 10.1038/s41598-018-32206-7.
|
| [46] |
Ye X, Lu Q, Yang A, et al. MiR-206 regulates the Th17/Treg ratio during osteoarthritis[J/OL]. Mol Med, 2021, 27(1): 64. DOI: 10.1186/s10020-021-00315-1.
|
| [47] |
Li X, Xiao S, Li F, et al. Max interacting protein 1 induces IL-17-producing T helper/regulatory T imbalance in osteoarthritis by upregulating tectonic family member 2[J/OL]. Tissue Cell, 2022, 78: 101906. DOI: 10.1016/j.tice.2022.101906.
|
| [48] |
Liu Z, Liu H, Li D, et al. Comprehensive analysis of m6A RNA methylation modification patterns and the immune microenvironment in osteoarthritis[J/OL]. Front Immunol, 2023, 14: 1128459. DOI: 10.3389/fimmu.2023.1128459.
|
| [49] |
Gao H, Peng L, Li C, et al. Salidroside alleviates cartilage degeneration through NF-κB pathway in osteoarthritis rats[J]. Drug Des Devel Ther, 2020, 14: 1445－1454.
|
| [50] |
Guo M, Liu H, Yu Y, et al. Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure[J/OL]. Gut Microbes, 2023, 15(1): 2190304. DOI: 10.1080/19490976.2023.2190304.
|